NR4A1 and Hyperinsulinemia: Chronic hyperinsulinemia downregulates sex hormone‐binding globulin (SHBG), leading to increased bioavailability of estrogen, a well‐known driver of BC, particularly in hormone receptor‐positive subtypes [34].